Bladder Cancer - Results from #160

Association of Caspase-8 Genotypes With Bladder Cancer Risk. September 19, 2019

Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Carcinoma. September 18, 2019

Improved antitumor efficacy of neutrophils stimulated by bacillus Calmette‑Guérin. September 18, 2019

Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients. September 18, 2019

Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer. September 18, 2019

Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer. September 17, 2019

Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer September 16, 2019

Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study. September 13, 2019

Aggressive treatment for urothelial cancer-complete urinary tract extirpation: Operative feasibility in two cases. September 13, 2019

Is liquid-based cytology an alternative to conventional cytology for detection of malignant cells in urine of bladder cancer? Eastern Indian prospective observational study. September 13, 2019

MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer. September 12, 2019

Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation. September 12, 2019

Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response. September 12, 2019

Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A. September 11, 2019

Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer. September 11, 2019

A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future 'MRI-PDD Fusion TURBT'. September 11, 2019

Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients. September 10, 2019

Clinical Complete Response after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Call for Standardized Assessments and Definitions. September 10, 2019

Trends in quality of life reporting for radical cystectomy and urinary diversion over the last four decades: A systematic review of the literature. September 10, 2019

Gemcitabine-Eribulin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma - Expert Commentary September 9, 2019

Page 9 of 317

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.